Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

5002 total record number 30 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 436 out of 501
5002 citations found

The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.

Carlson, PE;Walk, ST;Bourgis, AE;Liu, MW;Kopliku, F;Lo, E;Young, VB;Aronoff, DM;Hanna, PC;

Product: Toxin B from Clostridium difficile

  • … Toxin activity in culture supernatants was quantified based on a standard curve, which was generated using known concentrations of purified C. difficile toxin B (List Biological Laboratories, Inc). Assays were performed in triplicate for each isolate tested. …

In vivo optogenetic tracing of functional corticocortical connections between motor forelimb areas

Hira, R;Ohkubo, F;Tanaka, YR;Masamizu, Y;Augustine, GJ;Kasai, H;Matsuzaki, M;

Product: Anti-Cholera Toxin B Subunit (Goat)

Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation

Kurnellas, MP;Adams, CM;Sobel, RA;Steinman, L;Rothbard, JB;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Molecular assembly of botulinum neurotoxin progenitor complexes

Benefield, DA;Dessain, SK;Shine, N;Ohi, MD;Lacy, DB;

Product: Botulinum Neurotoxin Type A from Clostridium botulinum

  • Specimen Preparation and EM:

    The BoNT/A1 (Product #130), /B (Product #136), and /E (Product #141) PCs were purified by List Biological Laboratories and stored in lyophilized form.

Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine

Wui, SR;Han, JE;Kim, YH;Rhie, GE;Lee, NG;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Development and optimization of a novel assay to measure neutralizing antibodies against Clostridium difficile toxins

Xie, J;Zorman, J;Indrawati, L;Horton, M;Soring, K;Antonello, JM;Zhang, Y;Secore, S;Miezeiewski, M;Wang, S;Kanavage, AD;Skinner, JM;Rogers, I;Bodmer, JL;Heinrichs, JH;

Product: Toxin B from Clostridium difficile

  • MATERIALS AND METHODS

    Toxins:

    TcdA and TcdB were purchased from List Biological Laboratories, Inc. (Campbell, CA) and tgcBIOMICS GmbH (Mainz, Germany). List Biological Laboratories toxins were purchased in vials containing 20 to 25 g of lyophilized protein and stored at 4C. Toxins were reconstituted on the day of the assay to ensure maximum activity. tgcBIOMICS toxins were stored at 20C, and fresh aliquots were thawed as needed. Here, List Biological Laboratories is referred to as supplier 1, and tgcBIOMICS is referred to as supplier 2.

    C. difficile toxoid vaccine preparation:

    Lyophilized C. difficile TcdA and TcdB from supplier 1 (selected due to lower cost and availability of material) were each reconstituted and then buffer exchanged by dialysis into morpholinepropanesulfonic acid (MOPS)-buffered saline (for monkey immunization) or into 20 mM HEPES-buffered saline (pH 7.4) (for hamster immunization) to obtain final concentrations of 0.3 to 0.4 mg/ml based on the toxin quantity measured by the manufacturer. The toxins were converted to the toxoid state by addition of formaldehyde to 0.43% and lysine to 4.2 mg/ml and incubation for 16 to 18 days at 2C to 8C.

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Peanut Sensitization Protocol and Intraperitoneal Challenge:

    Female C57BL/6 mice (6-8 weeks old) were sensitized to peanuts by oral gavage treatment weekly with 1 mg peanut protein from Kraft peanut butter and 10 µg cholera toxin (List Biological Laboratories) in 100 µL of sterile water. …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

OT-II TCR transgenic mice fail to produce anti-ovalbumin antibodies upon vaccination

Leung, S;Smith, D;Myc, A;Morry, J;Baker, JR;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • Vaccines and immunization schedule:

    The vaccine was prepared by mixing 1 µg cholera toxin (CT) (List Biological Laboratories, Inc., Campbell, CA) with 20 µg endotoxin-free OVA (Hyglos, Germany) in a total volume of 12 µl PBS per mouse (6 µl per nare). …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Retinal drug delivery using eyedrop preparations of poly-L-lysine-modified liposomes

Sasaki, H;Karasawa, K;Hironaka, K;Tahara, K;Tozuka, Y;Takeuchi, H;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

  • … Immortalized human corneal epithelial cells (RIKEN Cell Bank, Tsukuba Science City, Japan) were cultured in DMEM/Ham’s F12 (1:1) supplemented with 10% FBS, 5 µg/ml insulin (Sigma), 0.1 µg/ml cholera toxin (List Biological Laboratories, Campbell, CA, USA), 0.5% DMSO …

    Product #100B – Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Regulation of Toll-like receptors in the choroid plexus in the immature brain after systemic inflammatory stimuli

Stridh, L;Ek, CJ;Wang, X;Nilsson, H;Mallard, C;

Product: ULTRA PURE LPS from Escherichia coli O55:B5

  • Administration of TLR Ligands:

    Postnatal day (PND) 8 mice were injected intraperitoneally (i.p.; 10 l/g body weight) … a TLR-3 ligand; LPS (List Biological Laboratories, Inc., ultrapure #423; 0.3 mg/kg), a TLR-4 ligand; … and were then deeply anesthetized and sacrificed 14 h postinjection for tissue sampling. …